12 completed, 5 unknown, 3 active not recruiting, 2 recruiting. 9 Not applicable, 5 Phase 1, 2 Phase 2, 2 Phase 4.
Follow Cancer of Liver: new trials by email Literature Review of Cancer of Liver trials Research Report on Cancer of Liver
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wet Heparinized Suction for Abdominal Cancer wet heparinzed suction, Microsieve, No heparin flush - Cancer of Pancreas, Cancer of Stomach | Not applicable | Withdrawn | H. Lee Moffitt Cancer Center and Research Institute | 2025-11-25 | 2026-09-17 | |
| Getting To Implementation: Improving Cancer Screening for Veterans Patient Navigation, Implementation Facilitation - Cancer of Liver, Cancer of Colon | Not applicable | Enrolling by invitation | University of Pittsburgh | 30300 | 2024-07-15 | 2026-07-31 |
| Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma PXS-5505 and Atezolizumab and Bevacizumab - Hepatocellular Carcinoma, Cancer of Liver | Phase 1 / Phase 2 | Withdrawn | University of Rochester | 2022-09-20 | 2023-07-13 | |
| Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma No intervention - Cancer of Liver | Completed | Zhejiang University | 522 | 2022-08-27 | 2023-06-18 | |
| Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer Nutritional consultant, Nutritional consultant + High-calorie, high-protein liquid nutrition supplement, Nutritional consultant + Liquid supplement + Powdered supplement 1 and 2 - Malnutrition, Cancer of Colon | Not applicable | Completed | Taipei Medical University | 66 | 2021-06-25 | 2023-05-31 |
| Onco-primary Care Networking to Support TEAM-based Care iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted), Control - Blood Pressure, Hypertension | Not applicable | Active not recruiting | Duke University | 313 | 2021-06-14 | 2026-02-20 |
| Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma no intervention - Cancer of Liver | Completed | Zhejiang University | 3769 | 2021-01-01 | 2022-12-09 | |
| Tempus Priority Study: A Pan-tumor Observational Study Observation - Breast Cancer, Prostate Cancer | Active not recruiting | Tempus AI | 1000 | 2020-10-19 | 2025-05-06 | |
| Low-dose Y90 Treatment Planning for HCC SIR-Spheres microspheres - HCC, Cancer of Liver | Not applicable | Completed | Emory University | 30 | 2019-12-16 | 2022-12-06 |
| Prospective Cohort of Patients With Hepatocellular Carcinoma in France Cancer of Liver, Hepatocellular Carcinoma | Recruiting | Centre Hospitalier Universitaire, Amiens | 5000 | 2019-09-26 | 2025-06-10 | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Cancer, All Types, Cancer of Liver | Unknown | SpeciCare | 1000 | 2019-03-21 | 2020-12-04 | |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver | Phase 1 / Phase 2 | Unknown | Leaf Vertical Inc. | 160 | 2019-01-15 | 2018-07-31 |
| Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Anlotinib - Cancer of Liver | Not applicable | Unknown | The First Affiliated Hospital with Nanjing Medical University | 40 | 2018-12-31 | 2018-12-11 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Clinical Trial Matching - Cancer, Metastatic, Cancer | Recruiting | Massive Bio, Inc. | 50000 | 2018-01-01 | 2025-10-28 | |
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer Cancer, Cancer of Pancreas | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 1000 | 2017-12-01 | 2023-06-22 | |
| Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients Semi-Structured interviews - Cancer of Liver, Diabetes | Unknown | Centre Hospitalier Universitaire de Besancon | 40 | 2017-07-26 | 2017-10-27 | |
| Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy Taiwan ACE Beads with doxorubicin - Cancer of Liver | Not applicable | Completed | National Cheng-Kung University Hospital | 12 | 2017-06-01 | 2018-10-22 |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) Radiation Therapy, Cancer | Completed | DxTerity Diagnostics | 16 | 2017-04-06 | 2024-08-07 | |
| Taiwan ACE Beads for Hepatoma Embolization Therapy Taiwan ACE Beads - Cancer of Liver | Not applicable | Completed | National Cheng-Kung University Hospital | 13 | 2016-04-01 | 2018-08-07 |
| A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors Metformin XR, Delayed Metformin, Sirolimus - Breast Neoplasms, Lung Neoplasms | Phase 1 | Completed | University of Chicago | 24 | 2014-04-01 | 2019-04-22 |
Showing 20 of 27. Sign in to see all of them.
Liver Neoplasms (27) · Pancreatic Neoplasms (10) · Neoplasms (9) · Colonic Neoplasms (8) · Carcinoma, Hepatocellular (7) · Esophageal Neoplasms (7) · Kidney Neoplasms (6) · Stomach Neoplasms (6) · Breast Neoplasms (5) · Prostatic Neoplasms (5) · Rectal Neoplasms (5) · Head and Neck Neoplasms (4) · Lung Neoplasms (4) · Ovarian Neoplasms (4) · Urinary Bladder Neoplasms (4)
Digestive System Diseases (27) · Digestive System Neoplasms (27) · Neoplasms by Site (27) · Liver Diseases (26) · Neoplasms (18) · Endocrine System Diseases (11) · Neoplasms by Histologic Type (11) · Endocrine Gland Neoplasms (10) · Gastrointestinal Diseases (10) · Pancreatic Diseases (10) · Gastrointestinal Neoplasms (9) · Neoplasms, Glandular and Epithelial (9) · Adenocarcinoma (8) · Colonic Diseases (8) · Intestinal Diseases (8)
Bevacizumab (2) · Dexmedetomidine (2) · Bortezomib (1) · Cannabidiol (1) · Capecitabine (1) · Fluorouracil (1) · Gemcitabine (1) · Irinotecan (1) · Leucovorin (1) · Observation (1) · Oxaliplatin (1) · Patient Navigation (1) · Sirolimus (1) · Temozolomide (1) · anlotinib (1)
National Cheng-Kung University Hospital (2) · Uppsala University Hospital (2) · Zhejiang University (2) · Catholic University of the Sacred Heart (1) · Centre Hospitalier Universitaire de Besancon (1) · Centre Hospitalier Universitaire, Amiens (1) · Copenhagen University Hospital, Rigshospitalet (1) · Duke University (1) · DxTerity Diagnostics (1) · Emory University (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · James A. Haley Veterans Administration Hospital (1) · Leaf Vertical Inc. (1) · Lisa H. Butterfield, Ph.D. (1) · Massive Bio, Inc. (1)
United States (14) · China (3) · Taiwan (3) · France (2) · Sweden (2) · Denmark (1) · Italy (1) · Puerto Rico (1)
Egidijus Semenas, MD, PhD (2) · Mats Eriksson, MD, PhD (2) · Xi-Zhang Lin (2) · David A Iannitti, MD (1) · Germano De Cosmo, PhD (1) · Ismail Kazem, MD (1) · James Pingpank, MD (1) · Jesper F Christensen, PhD (1) · Ken Dixon, MD (1) · Kristiyana Kaneva, MD, MS, MBA (1) · Ma Kuansheng, Ph.D (1) · Manish Sharma, M.D. (1) · Nabeel Badri (1) · Nima Kokabi, MD (1)
PMID 34794388, PMID 36075560, PMID 36650357, PMID 37988413, PMID 38861361, PMID 40783525, PMID 42786295
R01CA104524 (1)